Clinical Trial Update: Daclizumab and Sirolimus to Treat Uveitis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of daclizumab and sirolimus for uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Daclizumab (daclizumab)
• Sirolimus (Sirolimus)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Uveitis | Phase 1 | Status: COMPLETED